Healthcare provider profile · identity verified

Karla K Noel, MD

Family Practice · KAILUA KONA, HI · NPI 1457331936

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	329	97
Lisinopril	Lisinopril	189	56
Levothyroxine Sodium	Levothyroxine Sodium	164	45
Amlodipine Besylate	Amlodipine Besylate	140	43
Metformin Hcl Er	Metformin Hcl	92	25
Hydrochlorothiazide	Hydrochlorothiazide	89	27
Albuterol Sulfate Hfa	Albuterol Sulfate	80	23
Losartan Potassium	Losartan Potassium	71	21
Metoprolol Succinate	Metoprolol Succinate	64	21
Ozempic	Semaglutide	59	14
Ezetimibe	Ezetimibe	57	21
Rosuvastatin Calcium	Rosuvastatin Calcium	57	16
Omeprazole	Omeprazole	56	20
Allopurinol	Allopurinol	53	20
Metformin Hcl	Metformin Hcl	53	18
Prednisone	Prednisone	52	22
Alendronate Sodium	Alendronate Sodium	50	16
Eliquis	Apixaban	50	13
Tamsulosin Hcl	Tamsulosin Hcl	36	13
Atenolol	Atenolol	35	11
Trazodone Hcl	Trazodone Hcl	34	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Baclofen	Baclofen	32	15
Tramadol Hcl	Tramadol Hcl	32	suppressed
Valsartan	Valsartan	32	12
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Gabapentin	Gabapentin	31	14
Jardiance	Empagliflozin	29	suppressed
Methotrexate	Methotrexate Sodium	29	suppressed
Famotidine	Famotidine	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Cephalexin	Cephalexin	23	19
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Sertraline Hcl	Sertraline Hcl	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Mounjaro	Tirzepatide	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Furosemide	Furosemide	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Simvastatin	Simvastatin	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Azithromycin	Azithromycin	14	11
Celecoxib	Celecoxib	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Estradiol	Estradiol	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Glipizide	Glipizide	13	suppressed
Letrozole	Letrozole	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Glatiramer Acetate	Glatiramer Acetate	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Yuvafem	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error